Home/Anapole Technologies/Damian Antonescu

DA

Damian Antonescu

Manager, Investor Relations

Anapole Technologies

Therapeutic Areas

Oncology Infectious Disease

Anapole Technologies Pipeline

Drug	Indication	Phase
RGFields for HIV	HIV	Clinical (phase unspecified)
RGFields for Tuberculosis	Tuberculosis	Pre-clinical
RGFields for Oncology	Aggressive Cancers (e.g., Glioblastoma)	Pre-clinical

Leadership Team at Anapole Technologies

Stephen F. Botsford

Chief Executive Officer, Chairman of the Board

Joseph (Jodi) Startari

President, Board of Directors, Founder

Dr. Stephen Fausel

Stephen F. Botsford, Jr.

Board of Directors, Treasurer/Secretary

View full Anapole Technologies profile